Home Life Sciences Revealing the Potential of DNA-Based Vaccination: Lessons Learned from the Hepatitis B Virus Surface Antigen
Article
Licensed
Unlicensed Requires Authentication

Revealing the Potential of DNA-Based Vaccination: Lessons Learned from the Hepatitis B Virus Surface Antigen

  • Reinhold Schirmbeck and Jörg Reimann
Published/Copyright: June 1, 2005
Biological Chemistry
From the journal Volume 382 Issue 4

Abstract

DNAbased vaccination is a novel technique to efficiently stimulate humoral (antibody) and cellular (T cell) immune responses to protein antigens. In DNAbased vaccination, immunogenic proteins are expressed in in vivo transfected cells of the vaccine recipients in their native conformation with correct posttranslational modifications from antigenencoding expression plasmid DNA. This ensures the integrity of antibodydefined epitopes and supports the generation of protective (neutralizing) antibody titers. Plasmid DNA vaccination is furthermore an exceptionally potent strategy to stimulate CD8[+] cytotoxic T lymphocyte (CTL) responses because antigenic peptides are efficiently generated by endogenous processing of intracellular protein antigens. These key features make DNAbased immunization an attractive strategy for prophylactic and therapeutic vaccination against extra and intracellular pathogens. In this brief review, we summarize the current state of expression vector design, DNA delivery strategies, priming immune responses to intracellular or secreted antigens by DNA vaccines and unique advantages of DNA versus recombinant proteinbased vaccines using the hepatitis B surface antigen (HBsAg) as a model antigen.

:
Published Online: 2005-06-01
Published in Print: 2001-04-27

Copyright © 2001 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Vaccine Development: from Empirical Medicine to Molecularly Designed Therapy
  2. Dendritic Cells for Specific Cancer Immunotherapy
  3. Intracellular Bacteria as Targets and Carriers for Vaccination
  4. Bacteria-Mediated Transfer of Eukaryotic Expression Plasmids into Mammalian Host Cells
  5. Revealing the Potential of DNA-Based Vaccination: Lessons Learned from the Hepatitis B Virus Surface Antigen
  6. Progress toward a Malaria Vaccine: Efficient Induction of Protective Anti-Malaria Immunity
  7. Peptide Vaccines and Peptide Libraries
  8. Defined Synthetic Vaccines
  9. Antimicrobial Peptides: Properties and Applicability
  10. G-Quadruplex DNA Structures Variations on a Theme
  11. The Role of Heat Shock Proteins and Their Receptors in the Activation of the Immune System
  12. Transcriptional Repression Mediated by the KRAB Domain of the Human C2H2 Zinc Finger Protein Kox1/ZNF10 Does Not Require Histone Deacetylation
  13. Structure and Evolution of 4-Coumarate:Coenzyme A Ligase (4CL) Gene Families
  14. Inhibition of Hepatitis B Virus by Hammerhead Ribozyme Targeted to the Poly(A) Signal Sequence in Cultured Cells
  15. Chemical Accessibility of 18S rRNA in Native Ribosomal Complexes: Interaction Sites of mRNA, tRNA and Translation Factors
  16. C-Terminal Peptides of Interleukin-6 Modulate the Expression of junB Protooncogene and the Production of Fibrinogen by HepG2 Cells
  17. Proteome Analysis by Three-Dimensional Protein Separation: Turnover of Cytosolic Proteins in Hepatocytes
  18. Structural Intermediates in the Putative Pathway from the Cellular Prion Protein to the Pathogenic Form
  19. Local Variability of the Phosphoglycerate Kinase-Triosephosphate Isomerase Fusion Protein from Thermotoga maritima MSB 8
  20. Epigenetics of Latent Epstein-Barr Virus Genomes: High Resolution Methylation Analysis of the Bidirectional Promoter Region of Latent Membrane Protein 1 and 2B Genes
  21. The Cytosine N4-Methyltransferase M.PvuII Also Modifies Adenine Residues
  22. Expression of the Human Menkes ATPase in Xenopus laevis Oocytes
Downloaded on 9.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2001.068/html
Scroll to top button